Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome)
To access this article, please choose from the options below
L.A.B. has nothing to disclose. K.S.M. has nothing to disclose. C.L.W. has nothing to disclose. E.J.L. has nothing to disclose. B.S. has nothing to disclose.
Supported by funds from the intramural research program of the National Cancer Institute, National Institutes of Health.
PII: S0015-0282(09)03872-2
doi:10.1016/j.fertnstert.2009.10.012
Published by Elsevier Inc.

